Peripheral Arterial Interventional Devices - Global Strategic Business Report

The global market for Peripheral Arterial Interventional Devices was valued at US$8.7 Billion in 2025 and is projected to reach US$13.7 Billion by 2032, growing at a CAGR of 6.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Peripheral Arterial Interventional Devices Market - Key Trends & Drivers Summarized

Why Are Peripheral Arterial Interventions Critical for Managing Vascular Diseases?

Peripheral arterial interventional devices are used to diagnose and treat blockages or narrowing in arteries outside the heart, primarily in the limbs. These devices include angioplasty balloons, stents, atherectomy systems, guidewires, embolic protection devices, and drug-coated technologies. They are essential in treating peripheral artery disease (PAD), which affects circulation, mobility, and limb viability, especially in elderly and diabetic patients.

Minimally invasive peripheral interventions help restore blood flow, prevent limb amputation, and reduce symptoms such as claudication or ischemic ulcers. As PAD remains underdiagnosed yet increasingly prevalent worldwide, especially in aging populations, the need for reliable interventional solutions is growing in both primary and secondary vascular care settings.

How Are Devices Being Optimized for Complex and Recurrent Arterial Lesions?

Technological innovation in interventional tools has focused on navigating calcified, tortuous, or long lesions with minimal trauma. Drug-coated balloons (DCBs) and drug-eluting stents (DES) are becoming standard in femoropopliteal procedures due to their ability to inhibit restenosis. Atherectomy systems are being refined to debulk plaque effectively without damaging the vessel wall, supporting better long-term outcomes in heavily calcified arteries.

Wire-guided catheters, steerable sheaths, and real-time intravascular imaging tools are enhancing procedural accuracy. Bioabsorbable scaffolds and hybrid stents are under investigation for use in younger patients or those with high restenosis risk. Moreover, integrated procedural kits, including crossing devices and closure systems, are reducing procedural time and simplifying interventions in outpatient settings.

Where Is Clinical Use Expanding and Which Conditions Are Fueling Device Adoption?

Interventions for PAD are expanding rapidly across vascular centers, ambulatory surgical centers, and hybrid operating suites. North America and Europe lead in terms of adoption, owing to established PAD screening and reimbursement programs. However, Asia-Pacific is emerging as a high-growth region due to increasing incidence of diabetes, hypertension, and obesity-related vascular conditions.

Critical limb ischemia, chronic total occlusions, and complex femoral and below-the-knee lesions are key drivers of device use. As awareness improves among general practitioners and cardiologists, more patients are being referred earlier for diagnostic angiography and interventional management. Device demand is also increasing in high-risk populations with renal impairment, post-surgical graft occlusions, or failed prior stenting.

Growth in the Peripheral Arterial Interventional Devices market is driven by several factors

Growth in the peripheral arterial interventional devices market is driven by factors such as rising global prevalence of PAD, increasing preference for minimally invasive procedures, and continued innovation in drug-coated and atherectomy technologies. Improvements in procedural techniques, stent durability, and imaging guidance are making interventions safer and more effective across a wider range of patients.

Expansion of outpatient interventional programs, adoption of same-day discharge protocols, and integration of advanced closure systems are supporting market growth. As patient populations age and chronic vascular diseases become more prevalent, demand for specialized, high-precision peripheral intervention tools continues to increase. Clinical guidelines supporting early PAD intervention and technological progress in next-generation devices are reinforcing long-term growth in this segment.

Report Scope

The report analyzes the Peripheral Arterial Interventional Devices market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Type (Drug-Eluting Stents, Bare Stents, Ordinary Balloon, Drug-Eluting Balloon, Special Balloon); Application (Lower Limbs Application, Renal Artery Application, Carotid Artery Application)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Drug-Eluting Stents segment, which is expected to reach US$4.4 Billion by 2032 with a CAGR of a 5.8%. The Bare Stents segment is also set to grow at 5.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $2.4 Billion in 2025, and China, forecasted to grow at an impressive 10.1% CAGR to reach $2.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Peripheral Arterial Interventional Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripheral Arterial Interventional Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Peripheral Arterial Interventional Devices Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Laboratories, AngioDynamics Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Peripheral Arterial Interventional Devices market report include:

• Abbott Laboratories
• AngioDynamics Inc.
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cardinal Health (Cordis)
• Cook Medical
• Gore Medical (W. L. Gore & Associates)
• iVascular S.L.U.
• Kaneka Corporation
• Medtronic plc
• Merit Medical Systems Inc.
• MicroPort Scientific Corporation
• Penumbra Inc.
• Philips (Philips Healthcare)
• Shockwave Medical Inc.
• Surmodics Inc.
• Teleflex Incorporated
• Terumo Corporation

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.